Lunate Capital Ltd
Annual return '25
+16.6%
SPY '25
+17.7%
Alpha
-1.1ptsvs SPY
Invested
$120.4M
Holdings
6
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 99%. 3 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$RVMD
REVOLUTION MEDICINES INC
Q4 2025: Exited (was 2.20M shares)
44.4%
02
$SAIL
SAILPOINT INC
Q4 2025: Exited (was 3.00M shares)
33.0%
03
$LINE
LINEAGE INC
Q4 2025: Exited (was 600.0k shares)
16.3%
04
$NMRA
NEUMORA THERAPEUTICS INC.
Q4 2025: Exited (was 2.12M shares)
3.4%
05
$NAVN
NAVAN INC
Held since at least Q1 2024
2.2%
06
$RVMDW
REVOLUTION MEDICINES INC
Q4 2025: Exited (was 450.0k shares)
0.7%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 12:54 UTC.